vimarsana.com
Home
Live Updates
The U.S. Food & Drug Administration (FDA) Approves Updated L
The U.S. Food & Drug Administration (FDA) Approves Updated L
The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program
New data showing sustained complete renal response with LUPKYNIS through three years Monthly kidney function assessment no longer required after first year…
Related Keywords
United States ,
Rockville ,
New York ,
Maryland ,
Canada ,
Washington ,
Toronto ,
Ontario ,
Canadian ,
Canadians ,
Sanja Fidler ,
Diane Francis ,
Justin Trudeau ,
Joe Oconnor ,
Greg Keenan ,
Barbara Shecter ,
Gabriel Friedman ,
Andrea Christopher ,
Drug Administration ,
Postmedia Network Inc ,
European Commission ,
Us Food Drug Administration ,
Aurinia Pharmaceuticals ,
Aurinia Pharmaceuticals Inc ,
Clinical Program ,
National Post ,
Nvdia Ai Lab ,
American College Of Rheumatology ,
Corporate Communications Investor Relations ,
Nasdaq ,
Business Wire ,
Approves Updated ,
Long Term Data ,
Joeo Connor ,
Victoria Wells ,
Financial Times ,
Financial Post ,
New York Times ,
Chief Medical Officer ,
Postmedia Network ,
Top Stories ,
American College ,
Red Cell Aplasia ,
Drug Interactions ,
Prescribing Information ,
Boxed Warning ,
Medication Guide ,
Investor Inquiries ,
Investor Relations ,
Minister Justin Trudeau ,
United States Federal Reserve ,